Welcome to the European Society for Translational Antiviral Research

The European Society for translational Antiviral Research (ESAR) aims to unite scientists and clinicians throughout Europe to expand knowledge on resistant viruses and to investigate the molecular epidemiology of drug-resistant viruses in Europe from Public Health and scientific perspectives. ESAR will acts as a collaborative non-profit network for scientific studies, quality control, guidelines and training activities.

For more information about the Society please follow this link.


The CAPRE study (Combined Analysis of the Prevalence of drug Resistant HBV in antiviral therapy Experienced patients in Europe (CAPRE) by the HEPVIR working group has been published in The Journal of Infectious Diseases August 15th.

An interesting article about the CAPRE study has been written by Reuters. Please find the article here.

Button HepCare Database.JPG